Triple

T3781177
Position Surface form Disambiguated ID Type / Status
Subject Elliot Alderson E85418 entity
Predicate counteractsDrugWith P13821 FINISHED
Object Suboxone
Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
E387494 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Suboxone | Statement: [Elliot Alderson, counteractsDrugWith, Suboxone]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Suboxone
Context triple: [Elliot Alderson, counteractsDrugWith, Suboxone]
  • A. Substiane
    Substiane is a La Roche-Posay skincare line formulated to address loss of firmness, density, and comfort in mature or aging skin.
  • B. Nicorette
    Nicorette is a leading nicotine replacement therapy brand offering products like gum, lozenges, and patches to help people quit smoking.
  • C. Anpezan
    Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
  • D. Novafora
    Novafora was a semiconductor company known for acquiring Transmeta to expand its presence in low-power microprocessor and video processing technologies.
  • E. Lamotrek
    Lamotrek is a small atoll in the Federated States of Micronesia known for its traditional seafaring culture and navigational expertise.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Suboxone
Triple: [Elliot Alderson, counteractsDrugWith, Suboxone]
Generated description
Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Suboxone
Target entity description: Suboxone is a prescription medication combining buprenorphine and naloxone, primarily used to treat opioid dependence by reducing withdrawal symptoms and cravings.
  • A. Substiane
    Substiane is a La Roche-Posay skincare line formulated to address loss of firmness, density, and comfort in mature or aging skin.
  • B. Nicorette
    Nicorette is a leading nicotine replacement therapy brand offering products like gum, lozenges, and patches to help people quit smoking.
  • C. Anpezan
    Anpezan is a regional dialect of the Ladin language spoken in parts of the Dolomite area of northern Italy.
  • D. Novafora
    Novafora was a semiconductor company known for acquiring Transmeta to expand its presence in low-power microprocessor and video processing technologies.
  • E. Lamotrek
    Lamotrek is a small atoll in the Federated States of Micronesia known for its traditional seafaring culture and navigational expertise.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: counteractsDrugWith
Context triple: [Elliot Alderson, counteractsDrugWith, Suboxone]
  • A. usesDrug
    Indicates that an entity consumes, administers, or otherwise makes use of a specified drug.
  • B. isProdrugOf
    Indicates that one substance is a precursor form that is metabolized in the body to produce the active form of another substance.
  • C. inhibits
    Indicates that one entity prevents, restrains, or reduces the activity, effect, or occurrence of another entity.
  • D. usedAgainst chosen
    Indicates that one entity is employed, applied, or deployed in opposition to, or for the purpose of affecting, another entity.
  • E. hasCommonAdverseEffect
    Indicates that two or more entities share at least one adverse effect that occurs in response to them.
  • F. None of above.

Provenance (6 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69aed937fa8881908208ef3801060826 completed March 9, 2026, 2:29 p.m.
NER Named-entity recognition batch_69aee634c6ac819099653c660c286746 completed March 9, 2026, 3:24 p.m.
NED1 Entity disambiguation (via context triple) batch_69b4f04353a881908e612a10572eb8c5 completed March 14, 2026, 5:21 a.m.
NEDg Description generation batch_69b4f0e77efc8190b4459d4559261a2f completed March 14, 2026, 5:23 a.m.
NED2 Entity disambiguation (via description) batch_69b4f15cfde88190bcb2680b90f98111 completed March 14, 2026, 5:25 a.m.
PD Predicate disambiguation batch_69aee3d3c92c819081d9d5c45ef37a5d completed March 9, 2026, 3:14 p.m.
Created at: March 9, 2026, 3:12 p.m.